Genome Web Breaking News
Stat
- Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment
- STAT Plus: ‘We’re going to keep going’: A new clinical trial for ALS gives patients hope
- STAT Plus: A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change
- STAT Plus: Pharmalittle: Moderna gets $1.5 billion U.S. contract for Covid-19 vax; state out-of-pocket caps saved residents money
- Opinion: We need new antimicrobials to prevent the next infectious disease crisis
NYT science news
Xconomy news
- With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor
- Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia
- F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections
- Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political
- Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup
Fierce Biotech
- Life science incubator Paragon Biosciences grabs new CEO for investment arm
- Regeneron's Praluent sidekick nabs speedy FDA review, with February PDUFA date
- Researchers call out Gilead over diversity of remdesivir trials
- F2G raises $61M for late-phase antifungal R&D
- How a protein implicated in Alzheimer’s could enhance cancer immunotherapy
Fierce Medical Devices
- Alphabet’s Verily opens own lab to speed up COVID testing
- Medtronic snaps up smart insulin pen maker Companion Medical in a ‘bold move’
- LabCorp COVID tests free for three months to aide plasma donations
- Fractyl nets $55M for intestine-resurfacing trial in type 2 diabetes
- FDA approves Guardant’s tumor-sequencing blood test as a Tagrisso lung cancer diagnostic